Gilead Sciences, Inc. (Nasdaq:GILD) today announced new research to be presented at the European Association for the Study of ...

The closure of the Centers for Disease Control and Prevention (CDC)’s Division of Viral Hepatitis in the wake of the administration’s restructuring of the Department of Health and Human Services ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Fewer than 1 in 3 children with hepatitis C (HCV) see a clinician for care, and fewer than 1 in 8 receive treatment.

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor ...

Patna: Hot weather conditions have caused a spike in cases of gastro and liver-related diseases in the state capital.

The United Nations Children’s Fund has said Nigeria bears the highest global burden of unvaccinated children, with over two ...

Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people ...

The global target, he noted, is to reduce the number of zero-dose children by 25 per cent by 2025 and 50 per cent by 2030 ...

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the ...